Pane_1_Col_12_Title

Pharmaceuticals

Pane_1_Col_6_A

Addressing the Price of Pharmaceuticals

States face certain challenges in addressing the high list prices of drugs and state lawmakers are eager to find solutions to address these issues.

Pane_1_Col_6_B

Digging Into Prescription Drug Data: Affordability Boards and Transparency

New developments in prescription drugs are dramatically changing the options people have to treat their health conditions. To better understand the tradeoffs between drug prices, costs and access, legislators often look for data to inform their decisions.

PHARMACEUTICALS

Pharmaceuticals

All Documents

Pane_4_Col_4_8

Overview

Almost 50 percent of Americans take prescription drugs regularly, improving their health or even saving lives. State and federal legislative actions have led to major policy shifts, affecting drug costs, use of brands or generics and patient access and safety. Read reports on Medicaid use of preferred drug lists, new rebates from manufacturers, public and private patient assistance programs, medication adherence and patient education, “sunshine” laws, tighter regulation of safety violations at compounding pharmacies, combating illegal misuse of prescription products and future trends that affect a new generation of biological medications. Some results are dramatic: total U.S. drug spending was rising at a rate of 10 percent annually a decade ago, but recently the annual increase had slowed to less than 2 percent, then surged back 8.5 percent in 2015.